Dr. Trent's interests are in the clinical and translational research of sarcomas, direct care of sarcoma patients, and education about sarcoma and patient-oriented research. His research focuses on the discovery and detection of biomarkers for metastasis, progression and resistance to therapy in gastrointestinal stromal tumor (GIST) and other sarcomas including chondrosarcoma, dermatofibrosarcoma protuberans, myxoid liposarcoma, perivascular endothelial cell sarcoma (PEComa), angiomyolipoma, rhabdomyosarcoma and synovial sarcoma. Dr. Trent's research studies involve the use of novel preoperative/postoperative clinical trials, prospectively acquired tumor tissue, cell lines, archival tissue, as well as collaborations with disciplines such as the genomics facility, surgical oncology, pathology, radiology and interventional radiology.
Sarcoma Experimental Therapeutics.